大洋生物：第三季度归母净利润2953.1万元，同比增长48.92%

Core Insights - The company reported a revenue of 248 million yuan for Q3 2025, representing a year-on-year growth of 5.72% [1] - The net profit attributable to shareholders for Q3 2025 was 29.53 million yuan, showing a significant increase of 48.92% year-on-year [1] - For the first three quarters of 2025, the company achieved a total revenue of 747 million yuan, which is an 11.24% increase compared to the same period last year [1] - The net profit attributable to shareholders for the first three quarters reached 80.04 million yuan, reflecting a robust growth of 56.12% year-on-year [1]